Label: SODIUM CITRATE AND CITRIC ACID solution
-
NDC Code(s):
62135-434-47,
62135-868-24,
62135-868-51,
62135-869-24, view more62135-869-43
- Packager: Chartwell RX, LLC
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated May 31, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
-
DESCRIPTION
Sodium Citrate and Citric Acid Oral Solution, USP is a clear stable and cherry flavored systemic alkalizer containing sodium citrate and citric acid in a sugar-free base with cherry flavor. It is a nonparticulate neutralizing buffer.
Sodium Citrate and Citric Acid Oral Solution, USP contains in each teaspoonful (5 mL):
Sodium Citrate Dihydrate, USP 500 mg (0.34 Molar)
Citric Acid Monohydrate, USP 334 mg (0.32 Molar)Each mL contains 1 mEq sodium ion and is equivalent to 1 mEq bicarbonate (HCO 3).
INACTIVE INGREDIENTS: purified water, saccharin sodium, sodium benzoate, sorbitol solution, and wild cherry flavor.
-
CLINICAL PHARMACOLOGY
Sodium citrate is absorbed and metabolized to sodium bicarbonate, thus acting as a systemic alkalizer. The effects are essentially those of chlorides before absorption and those of bicarbonates subsequently. Oxidation is virtually complete so that less than 5% of sodium citrate is excreted in the urine unchanged.
-
INDICATIONS AND USAGE
Sodium citrate and citric acid oral solution, is an effective alkalinizing agent. It is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. This product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively.
Sodium citrate and citric acid oral solution is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. This product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. This product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods.
- CONTRAINDICATIONS
-
PRECAUTIONS
Sodium citrate and citric acid oral solution should be used with caution by patients with low urinary output unless under the supervision of a physician. This product should not be administered concurrently with aluminum-based antacids. Patients should be directed to dilute adequately with water and preferably, to take each dose after meals to avoid saline laxative effect. Sodium salts should be used cautiously in patients with cardiac failure, hypertension, impaired renal function, peripheral and pulmonary edema, and toxemia of pregnancy. Periodic examinations and determinations of serum electrolytes, particularly serum bicarbonate level, should be carried out in those patients with renal disease in order to avoid these complications.
-
ADVERSE REACTIONS
Sodium citrate and citric acid oral solution is generally well tolerated, without any unpleasant side effects, when given in recommended doses to patients with normal renal function and urinary output. However, as with any alkalinizing agent, caution must be used in certain patients with abnormal renal mechanisms to avoid development of alkalosis, especially in the presence of hypocalcemia.
- OVERDOSAGE
-
DOSAGE AND ADMINISTRATION
Sodium citrate and citric acid oral solution should be taken diluted in water, followed by additional water, if desired. SHAKE WELL BEFORE USING.
For Systemic Alkalization
Usual Adult Dose
2 to 6 teaspoonfuls (10 to 30 mL), diluted in 1 to 3 ounces of water, after meals and at bedtime, or as directed by a physician.
Usual Pediatric Dose
1 to 3 teaspoonfuls (5 to 15 mL), diluted in 1 to 3 ounces of water, after meals and at bedtime, or as directed by a physician. For children under two years of age, use is based on consultation with a physician.
As a neutralizing buffer
3 teaspoonfuls (15 mL), diluted with 15 mL water, taken as a single dose, or as directed by a physician.
-
HOW SUPPLIED
Sodium Citrate and Citric Acid Oral Solution, USP (Colorless liquid with cherry flavor) is supplied in the following oral dosage form:
473 mL (16 fl oz) bottle : NDC 62135-434-47
Unit Dose Cup 15 mL : NDC 62135-868-51
20 Unit Dose Cups of 15 mL each : NDC 62135-868-24
Unit Dose Cup 30 mL : NDC 62135-869-43
20 Unit Dose Cups of 30 mL each : NDC 62135-869-24STORAGE:
Keep tightly closed. Store at controlled room temperature, 20°-25°C (68°-77°F). Protect from freezing.
Rx ONLY
Manufactured for:
Chartwell RX, LLC
Congers, NY 10920L71144
Rev. 03/2024
-
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL
Sodium Citrate and Citric Acid Oral Solution, USP 500 mg/334 mg per 5 mL - NDC 62135-434-47 - 473 mL Bottle Label
Sodium Citrate and Citric Acid Oral Solution, USP 1500 mg/1002 mg per 15 mL - NDC 62135-868-51 - 15 mL Unit Dose Label
Sodium Citrate and Citric Acid Oral Solution, USP 3000 mg/2004 mg per 30 mL - NDC 62135-869-43 - 30 mL Unit Dose Label
-
INGREDIENTS AND APPEARANCE
SODIUM CITRATE AND CITRIC ACID
sodium citrate and citric acid solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:62135-434 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM CITRATE (UNII: 1Q73Q2JULR) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) SODIUM CITRATE 500 mg in 5 mL CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID 334 mg in 5 mL Inactive Ingredients Ingredient Name Strength SACCHARIN SODIUM (UNII: SB8ZUX40TY) SODIUM BENZOATE (UNII: OJ245FE5EU) SORBITOL SOLUTION (UNII: 8KW3E207O2) WATER (UNII: 059QF0KO0R) Product Characteristics Color white (clear) Score Shape Size Flavor CHERRY Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:62135-434-47 473 mL in 1 BOTTLE; Type 0: Not a Combination Product 12/08/2022 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 12/08/2022 SODIUM CITRATE AND CITRIC ACID
sodium citrate and citric acid solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:62135-868 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM CITRATE (UNII: 1Q73Q2JULR) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) SODIUM CITRATE 1500 mg in 15 mL CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID 1002 mg in 15 mL Inactive Ingredients Ingredient Name Strength SACCHARIN SODIUM (UNII: SB8ZUX40TY) SODIUM BENZOATE (UNII: OJ245FE5EU) SORBITOL SOLUTION (UNII: 8KW3E207O2) WATER (UNII: 059QF0KO0R) Product Characteristics Color white (clear) Score Shape Size Flavor CHERRY Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:62135-868-24 2 in 1 BOX 05/30/2024 1 10 in 1 TRAY 1 NDC:62135-868-51 15 mL in 1 CUP; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 12/08/2022 SODIUM CITRATE AND CITRIC ACID
sodium citrate and citric acid solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:62135-869 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM CITRATE (UNII: 1Q73Q2JULR) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) SODIUM CITRATE 3000 mg in 30 mL CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID 2004 mg in 30 mL Inactive Ingredients Ingredient Name Strength SACCHARIN SODIUM (UNII: SB8ZUX40TY) SODIUM BENZOATE (UNII: OJ245FE5EU) SORBITOL SOLUTION (UNII: 8KW3E207O2) WATER (UNII: 059QF0KO0R) Product Characteristics Color white (clear) Score Shape Size Flavor CHERRY Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:62135-869-24 2 in 1 BOX 05/30/2024 1 10 in 1 TRAY 1 NDC:62135-869-43 30 mL in 1 CUP; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 12/08/2022 Labeler - Chartwell RX, LLC (079394054)